Opus Genetics to present OPGx-BEST1 Cohort 1 topline data
Topline Phase 1/2 Cohort 1 data from the OPGx-BEST1 gene therapy program will be presented on Sept. 9 at 8:00 a.m. ET in an investor webcast and conference call.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.